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FILTERED extracts, usually from neoplastic tissues, can induce leukaemias in
newborn or adult mice of certain strains (Gross, 1957a; Graffi, 1957; Friend,
1957; Schwartz and Schoolman, 1959). Gross has shown that such extracts
from tissues of high-leukaemic strain mice with spontaneous lymphocytic leukae-
mias, when injected at birth into mice of low-leukaemic strains, will ultimately
produce leukaemia in about a third of the recipient mice (Gross, 1958b). The
resulting leukaemias were transplantable by cell graft in most cases to adult mice
of the recipient line but only rarely to the donor strain in which the original
leukaemia occurred.
Only newborn mice less than 16 hours after birth were found initially to be
susceptible to the leukaemogenic activity of the extracts. When, however, the
extracts were passed serially through several generations ofsusceptible mice, their
potency was increased and young adult mice could be successfully inoculated
(Gross, 1958c). Marked inter- and intra-strain sensitivity has been found in the
response ofthe mice to inoculation ofthe extracts. In the C3H strain, for instance,
the C3Hf/Gs subline is the most susceptible (Woolley and Small, 1957) while the
C3Hf/An subline is hardly sensitive (Gross, 1955a). The necessity of using new-
born mice and the marked differences in strain and substrain susceptibility have
suggested the possibility that the disease only develops in mice that can acquire
immune tolerance to the leukaemic agent (Harris, 1958; Barnes et al., 1959).
A series ofinvestigations has been commenced in this laboratory in an attempt
to elucidate the mechanism of leukaemogenesis by cell-free extracts of leukaemic
tissues. The present paper reports the results obtained in four different strains of
mice inoculated as newborn or as adults with filtered extracts. A further paper is
concerned with the role of the thymus in leukaemogenesis by cell-free filtrates of
leukaemic tissues (Miller, 1960). A preliminary account of these studies has
already been given (Miller, 1959).
MATERIALS AND METHODS
Mice.-Experiments were carried out on mice of four different inibred strains
(Table I). IJibreeding in mice of all four strains has been maintained by strict
sib-matings in our laboratory at Pollards Wood since the time oftheir acquisition.
Filtrates.-Cell-free filtrates were prepared from freshly obtained tissues by a
method closely following that of Gross (1958b). The tissues were homogenized inJ. F. A. P. MILLER
TABLE I.-Source and Date of Acquisition of Inbred Strains
Date
Strain acquired Source
C3Hf/PW . 1938 . Bittner.
C3Hf/Gs . . 1958 . Gross via Woolley.
CBA/H . . 1949 . Harwell.
Aki . . . 1945 . Furth via Engelbreth-Holm.
ice-cold saline with a previously chilled mortar and pestle so as to make a 20 per
cent homogenate. This was centrifuged in a Servall centrifuge at 1400 g for 15
minutes in the cold room. The supernatant fluid was then centrifuged at 7000 g
for 10 minutes and the final supernatant fluid filtered through a chilled Selas 02
porosity filter candle under vacuum pressure. The extracts were either used
immediately or sealed in 2 ml. glass ampoules and stored at -790 C.
The extracts were prepared from thymus, spleen and lymph nodes ofmice with
either spontaneous or induced leukaemias: the spontaneous leukaemias were
obtained from our own colony of Aki and from AKR mice received from other
laboratories; the inducedleukaemias were obtainedfrom C3Hf/Gs mice inoculated
by Dr. Gross with his potent Passage A filtrate (Gross, 1957b).
Inoculation procedures.-Filtrates were generally injected into newborn mice
less than 16 hours after birth, each baby mouse receiving 041 ml. by the intraperi-
toneal route, the needle first traversing the thigh muscles to avoid leakage. When
Passage A filtrate was used however, suckling mice up to 14 days of age were
injected, the volume of the inoculum being varied according to age: at 1 and 2
days 0-1 ml. was given, at 3 and 4 days 0-2 ml. and at 5 to 14 days 0-3 ml. Adult
mice inoculated with filtrates received 0.5 ml. intraperitoneally daily for 3 days.
Control mice were usually littermates identified by tail-clipping; they received
either saline of filtrates heated to 56° C. for 30 minutes.
Transplantation of leukaemias.-For transplantation of leukaemias, cell sus-
pensions were prepared from fresh leukaemic spleen by teasing out with forceps
in a dish of saline. The cells were washed in saline to the desired volume so that
0 5 ml. of the suspension contained 30 to 50 million cells. This amount was
injected intraperitoneally into adult mice of the strains tested for transplant-
ability. The cells of each case ofleukaemia to be transplanted were injected into
3 to 5 mice ofeach strain.
Induction of immune tolerance.-For induction of specific immune tolerance to
Ak tissues, cell suspensions from thymus or spleen of one-month-old healthy Aki
donors were prepared by teasing out in buffered Ringer phosphate solution,
washing twice, and resuspending in the buffered solution so that 0U05 ml. of the
suspension contained 5 to 7 million cells. This amount of the freshly prepared
suspension was injected into the anterior facial vein of newborn C3Hf/PW mice
less than 20 hours after birth.
Skin grafts.-Skin grafts were performed according to the method of Billing-
ham and Medawar (1951) at 6 to 8 weeks of age. The grafted skin was from 2-
months-old healthy Aki female mice and served as the external indicator of the
tolerant state. Only fully tolerant mice, carrying healthy skin grafts were used
experimentally.
Histology.-Tissues for histological examination were fixed in Bouin's fluid and
stained in haematoxylin and eosin.
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RESULTS
Detailed results are presented in Tables II to VIII. The salient features of
these tables may be summarized as follows.
Incidence ofspontaneous leukaemia (Table II)
Only the Aki strain had a high incidence of spontaneous leukaemia during the
fourteen month period of observation. The final figures for the full life span of
the low-leukaemic strains may well be rather different.
TABLE II.-Incidence of Spontaneous Lymphocytic Leukaemia























Incidence of lymphocytic leukaemia in mice inoculated at birth with cell-free extracts
of leukaemic tissues (Table III)
(a) Controls.-The saline and heat-inactivated filtrate controls in all cases did
not have a significantly different incidence of leukaemia from the completely
untreated mice.
TABLE III.-Incidence of Lymphocytic Leulkaemia in Mice Following




























* Survivors are over 12 to 14 months of age.
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(b) Filtratesfrom Ak leukaemic tissues.-Filtrates from leukaemic Ak mice had
a marked effect only in Aki mice where the average age of onset of the disease was
reduced from about 9 months to about 5 months. This effect must be regarded
as an acceleration of the leukaemogenic process. The total incidence of the
disease in the inoculated group was slightly lower than in the completely untreated
group as a result of a higher mortality from non-leukaemic causes in inoculated
mice.
A slightly increased incidence of leukaemia was observed in C3Hf/PW and
CBA/H mice following injection of Ak leukaemic filtrates at birth.
Thirty-one separate Ak filtrates were used in these experiments but only 8
were associated with leukaemogenic activity in C3Hf/PW and CBA/H mice
(Table IV). Five filtrates each produced leukaemia in 2 mice and in 3 cases the
2 mice came from the same litter. Sixteen of the filtrates used were responsible
for the development of early leukaemias in inoculated Aki mice.
(c) Passage A filtrate.-Injection ofPassage A filtrate at or soon after birth gave
100 per cent incidence of leukaemia in both C3Hf/Gs and Aki mice as early as 2 to
4 months. This filtrate increased the incidence of leukaemia following injection
into newborn C3Hf/PW mice to about 27 per cent the disease developing between
7 and 10 months of age.
TABLEIV.-Activity of Filtrates from Tissues of Ak Mice with Spontaneous Leukaemia
Recipients (inoculated at birth) -
Low-leukaemic C3Hf/PW High-leukaemic Aki mice
and CBA /H mice ,-
______________________________________ 5Incidence of early
Number Leukaemia Number (3-6 months)
Number Number of incidence Number Number of leukaemia
of of mice suscept-
, of of mice suscept- A
Source of active inocu- ible Per active inocu- ible Per
fitrates filtrates lated litters Number cent filtrates lated litters Number cent
Akj(Pollards Wood) 5/15 73 6/26 7 9-6 10/14 40 15/18 27 67-5
AKR(Manchester). 1/8 32 2/10 2 6-3 3/5 17 3/5 11 64-7
AKR(Gif-sur-Yvette) 1/4 19 1/4 2 10- 5 2/3 9 2/3 7 77-8
AKR (Paris)
. . 1/4 15 1/4 2 13-3 1/2 9 2/3 6 66-7
Total
. . 8/31 139 10/44 13 9-4 16/24 75 22/29 51 68-0
Transplantability of the leukaemias
Seven of the leukaemias produced in C3Hf/PW after injection of filtrates of
Ak leukaemic tissues were tested for transplantability in Aki and C3Hf/PW mice.
All were transplantable to C3Hf/PW and 3 to Ak mice as well. Twenty-four
Passage A induced leukaemias in C3Hf/Gs mice were transplanted. All were
transplantable to C3Hf/Gs and 15 also to Aki. Three leukaemias arising in CBA/H
mice were transplantable only to CBA/H mice.
The development of a potent Ak filtrate (Table V)
Filtrates from Ak leukaemic tissues was passed through serial cell-free in-
oculations into 4 successive generations of newborn Ak mice. In each passage,
the first Ak mouse that developed leukaemia was used as donor for the preparation
86LEUKAEMOGENESIS BY CELL-FREE FILTRATES
TABLE V.-The Incidence of Lymphocytic Leukaemia in C3Hf/Gs Mice Following
Inoculation of Ak Leukaemic Filtrates Passaged Serially Through Ak Mice
Filtrate given
at birth
Ak leukaemic (from spontaneous case)
Ak leukaemic (after 3 passages in Ak
mice)

















* These mice were inoculated between 1 and 5 days after birth.
of the next passage-extract. The final filtrate considerably increased the total
incidence of the disease and accelerated the average age of onset when inoculated
into C3Hf/Gs mice at or soon after birth.
TABLE VI.-Incidence of Lymphocytic Leukaemia in Mice Following Inoculation
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Ak leukaemic
C3Hf/Gs . Passage A
Aki . Ak leukaemic




















The incidence of lymphocytic leukaemias in mice inoculated as adults with cell-free
extracts of leukaemic tissues (Table VI)
Cell-free filtrates of leukaemic tissues of Ak mice were not capable ofinducing
leukaemias in adult C3Hf/Gs or C3Hf/PW mice. Though a high number ofAki
mice developed leukaemia following injection at 4 to 8 weeks of age with filtrates
of Ak leukaemic tissues, the total incidence and average age of onset were almost
the same as in untreated Aki mice. It must, therefore, be assumed that the
filtrates had no noticeable effect when injected into adult mice.
Passage A filtrate given to C3Hf/Gs at 4 to 8 weeks of age did produce some
leukaemias but not as efficiently as the same filtrate given at or soon after birth.
The incidence of lymphocytic leukaemia in C3Hf/PW mice tolerant to Ak, and
inoculated as adults with cell-free extracts ofAk leukaemic tissues (Table VIII)
An intravenous injection of healthy Ak* spleen or thymus cells into newborn
C3Hf/PW mice induced long-lasting tolerance to Aki skin grafts in up to 90 per
cent of the mice (Table VII). Transplants of Ak leukaemic cells grew progress-
ively in all cases in tolerant C3Hf/PW mice but never in non-tolerant mice. On
further transplantation to groups ofnon-tolerant C3 annd of Ak mice the trans-
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TABLE VII.-Tolerance to Ak Skin Graft in C3Hf/PW Mice
Inoculated at Birth with Ak Spleen or Thymus Cells
Ak cells given
at birth Number of
A- 5 mice in Number of mice
Number Type group fully tolerant
5-7 million Spleen . 143 . 128 (89%)*
5-7 million Thymus . 161 . 137 (85%)*
0 57 (0%)t
* Ak skin graft intact to date (over 12 months).
t Ak skin graft rejected in 11 ± 1 days.
plants were successfully established only in Ak mice thus showing that the genetic
constitution of the transplanted leukaemia was still Ak.
TABLE VIII.-Incidence of Lymphocytic Leukaemia in C3Hf/PW Mice Tolerant
to Ak Following Inoculation of Ak Leukaemic Extracts at 4 to 6 Weeks of Age
Number Mice with leukaemia
Intravenous injection Filtrate given at of mice r -- - -
at birth 4 to 6 weeks in group Number Age Per cent
Ak spleen cells . Ak leukaemic . 31 . 0 0
Ak thymus cells . . 28 . 0 0
Ak spleen or thymus cells None . 20 . 0 - 0
No leukaemia occurred in C3Hf/PW mice made tolerant to Ak and injected 1
month after birth with cell-free filtrates from Ak leukaemic tissues (Table VIII).
Sixteen of the mice in this group received at least one of the 8 filtrates that was
associated with leukaemogenic activity following inoculation into newborn
C3Hf/PW or CBA/H mice.
DISCUSSION
The work described here confirms the results obtained by Gross (1958b) and
others (Woolley and Small, 1956; Furth et al., 1956; Dulaney et al., 1957; Hays
and Beck, 1958; Kassel and Rottino, 1959).
Cell-free extracts of tissues of Ak mice with spontaneous leukaemia are clearly
capable of leukaemogenic activity. In the high-leukaemia Ak strain and in the
(AKRXC3Hf)Fl hybrids, there is little or no change in leukaemia incidence but
an acceleration of the onset of the disease following inoculation of extracts at
birth (Rudali, Duplan and Latarjet, 1957; Law, Dunn and Boyle, 1955). The
leukaemic agent has been shown to be present in young healthy Ak mice (Gross,
1951, 1953), so that inoculation of leukaemic extracts into these mice must be
assumed to increase the quantity of agent already present in the host. Accele-
ration of leukaemia may thus be explained on a purely quantitative basis. Ex-
tracts from normal tissues oflow-leukaemic C3H mice failed to be associated with
leukaemogenic activity following inoculation into newborn C3H mice (Gross,
1955b). These mice may, therefore, not carry the leukaemic agent, and leukaemia
occurring as a result of inoculation of Ak leukaemic extracts must presumably
have been induced by the agent. It is true, however, that the disease occurs
spontaneously in low-leukaemic strain mice (Law, 1957) and two cases have been
diagnosed in our colony of C3Hf/PW kept under observation for only 14 months.
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These two cases still have to be explained. It is possible that some of the C3H
mice carry the agent, but that our methods are not sensitive enough to demon-
strate its presence ? If this is so, does the inoculation of leukaemic filtrate at
birth simply accelerate the onset of the disease in mice that would develop it if
they lived long enough ? Some agent must be present in C3H mice since Gross
claims to have activated it by X-irradiation (Gross, 1958a). The point at issue
is whether this agent is or is not identical to that present in high-leukaemia strains.
Filtrates from Ak leukaemic tissues have been shown to vary considerably in
their activity. Many of them were associated with the development of early
leukaemia in Ak mice, but only few produced leukaemia in C3Hf/PW mice
(Table IV). Gross developed his potent Passage A filtrate (Gross, 1957b) by
selecting an active Ak leukaemic extract and passing it through serial cell-free
inoculation of newborn C3Hf/Gs mice. In the work reported here, a potent
extract was obtained in a similar way but in a relatively shorter period of time,
the extracts being passed through successive generations of newborn Ak mice
instead of C3Hf/Gs mice (Table V). No doubt this procedure must select and
concentrate active agent, since dilution ofthe final potent extract reduces the total
incidence and delays the average age of onset of leukaemia in inoculated mice
(Gross and Dreyfuss, 1959).
Subline differences exist in respect to susceptibility to leukaemogenesis by any
given extract as was pointed out by Gross (1955a) and Woolley and Small (1957).
In this study, a valid comparison can be made of the response of 2 sublines of
C3H mice, both originally obtained from Bittner, since both were injected simul-
taneously with the same filtrate, Passage A. It is obvious from Table III that
the C3Hf/Gs subline is by far the more sensitive.
Only newborn mice were susceptible to the leukaemogenic activity of filtrates
prepared from tissues of Ak mice with spontaneous leukaemia. This may be due
to:
(1) A state of immunological unresponsiveness;
(2) a concentration effect;
(3) factors, other than immunological, inherent to the particular stage
of development of the animals at birth.
(1) It has been suggested that immunological tolerance is the reason why only
newborn mice are susceptible to an agent recently isolated from a foreign strain
(Harris, 1958; Barnes et al., 1959). In this study, a state of acquired tolerance
in C3H mice to transplantation antigens of Ak mice did not appear to give toler-
ance to the Ak leukaemic agent (Table VIII). The mice were fully susceptible
to grafts of Ak leukaemic cells but not to the leukaemogenic activity of the Ak
agent. For the induction oftolerance, normal Ak cells, which according to Gross
(1953, 1959) contain the agent, were injected intravenously at birth, and yet no
leukaemia developed. Perhaps the quantity of agent in 5 million normal Ak
cells is not sufficient for leukaemogenesis, or perhaps the agent is intracellular,
antigenically distinct and must be introduced in the free state in newborn animals.
(2) Simple quantitative factors may serve to explain the age susceptibility to
the leukaemogenic effect of cell-free filtrates. For any active filtrate, the con-
centration of agent present in the newborn after inoculation must be relatively far
greater than that which can be attained in an adult mouse. Augmentation of
" infectivity " presumably occurs as a result ofselection ofthe most active extract
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after serial passage through successive generations of mice of any one strain. A
far greater concentration of active agent can then be achieved following inocu-
lation into suckling or young adult mice. This may explain why acceleration of
leukaemia in Ak mice by Ak filtrate can only occur when the filtrate is given at
birth, and why, on the other hand, Passage A can accelerate Ak leukaemia when
given to older Ak mice or can produce leukaemia after inoculation into young
adult C3Hf/Gs mice.
(3) Shubik has pointed out that the response of newborn mice to filtrates
should also be viewed as a response of a sensitive biological system to carcino-
genesis (Pietra, Spencer and Shubik, 1959). He reports a high incidence of early
malignant lymphomas in a relatively insusceptible strain of mice following the
inoculation at birth of a single low dose of chemical carcinogen.
All the leukaemias developing in our inoculated mice were lymphoid with
thymus involvement resembling typical spontaneous lymphomas in Ak mice.
They were all transplantable to mice of the recipient line, and many were trans-
plantable to both donor and recipient strains. This confirms similar observations
made by Furth et al. (1956) and Gross (1958c). No other tumours, nor tumours
characteristic of polyoma virus infection (Stewart et al., 1957) were seen in any of
the mice of the present series in contrast to the results of other workers in this
field (Stewart, 1955 ; Law et al., 1955 ; Salaman, 1959). Salaman, for instance,
recorded the occurrence of 40 tumours (but no leukaemia) among 15 out of 23
C3Hf/Bi mice inoculated at birth with leukaemic filtrate. However, the filtrates
were prepared from leukaemias that had already been transplanted three times
by cell graft through AKR mice. Gross has stressed that as far as leukaemo-
genesis by cell-free extracts is concerned, the source of material should either be
a spontaneous leukaemia or one induced with leukaemic extracts rather than a
transplanted leukaemia (Gross, 1956, 1958b). Some supporting evidence for this
claim was obtained by Kassel and Rottino (1959) who showed that extracts
prepared from transplanted AKR leukaemic tissues resulted in the development
of parotid tumours, adrenal tumours, osteosarcomas and fibromyxomas but no
leukaemia.
It would be pure speculation to attempt, on the basis of the present results,
to identify the agent in leukaemic filtrates as a virus or as a genic complex derived
from either neoplastic or potentially neoplastic cells. An increase in leukaemia
incidence, per se, does not establish the existence of a virus-mediated mechanism.
Final identification of the agent must await further investigations of its biological
and physicochemical properties.
SUMMARY
1. Newborn or adult mice of the low-leukaemic strains C3Hf/PW, C3Hf/Gs,
CBA/H, and of the high-leukaemic strain Aki were inoculated intraperitoneally
with cell-free extracts prepared from tissues of Ak mice with spontaneous leuk-
aemia, and of C3Hf/Gs mice with leukaemias induced by leukaemic filtrate,
Passage A.
2. Ak leukaemic filtrates inoculated into newborn low-leukaemic strain mice
resulted in leukaemia in 11-8 per cent of 68 C3Hf/PW mice at 7 to 14 months and
7 per cent of 71 CBA/H mice at 6 to 15 months. No leukaemia occurred when
these filtrates were inoculated into 34 adult C3Hf/PW mice or 18 adult C3Hf/Gs
mice.
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3. Passage A filtrate resulted in 26-7 per cent leukaemias at 7 to 10 months
when inoculated into 45 newborn C3Hf/PW mice and 100 per cent leukaemia at
2 to 4 months following inoculation into 87 one- to 14-days-old C3Hf/Gs mice.
The same filtrate produced 60 per cent leukaemias when inoculated into 20 one-
to 2-months-old C3Hf/Gs mice.
4. Acceleration of the onset of leukaemia to 3 to 6 months occurred in 68 per
cent of 75 Ak mice inoculated at birth with Ak leukaemic filtrates but in none of
18 Ak mice inoculated at 1 to 2 months of age. Passage A filtrate accelerated
leukaemia in 100 per cent of 15 Ak mice inoculated between 1 and 14 days of age.
5. Transplantation of some of the leukaemias produced in C3H mice revealed
some ambivalence: all were transplantable to C3H mice but many were also
transplantable to mice of the original donor Ak strain.
6. Increase in potency of an Ak leukaemic filtrate was evident after 4 serial
cell-free inoculations of newborn Ak mice. The final filtrate was associated with
the development of leukaemia at 3 to 6 months in 68.8 per cent of 16 C3Hf/Gs
mice inoculated between 1 and 5 days.
7. No leukaemia developed in 79 C3Hf/PW mice which received at birth an
intravenous injection of normal spleen and thymus cells from healthy young
adult Ak mice. Fifty-nine of these mice received, in addition, intraperitoneal
injections of Ak leukaemic filtrate at 4 to 8 weeks of age. All the mice in this
group were fully tolerant of Ak skin grafts.
8. Only lymphocytic leukaemias or lymphoid tumours confined to the thymus
were seen in mice ofthe present series. No other tumours such as those described
by other workers in this field have appeared.
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